Biological significance of amino acid substitutions in hepatitis B surface antigen (HBsAg) for glycosylation, secretion, antigenicity and immunogenicity of HBsAg and hepatitis B virus replication

Journal of General Virology

Volumn 91, Issue 2, 2010, Pages 483-492

  Wu, Chunchen ^a   Zhang, Xiaoyong ^b   Tian, Zhang ^c   Song, Jianhua ^a   Yang, Dongliang ^c   Roggendorf, Michael ^b   Lu, Mengji ^a   Chen, Xinwen ^b,d  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AMINO ACID; ASPARAGINE; DNA; GLYCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; ISOLEUCINE; LYSINE; THREONINE; HEPATITIS B ANTIBODY;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENETIC TRANSFECTION; GLYCOSYLATION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOASSAY; IMMUNOFLUORESCENCE; IMMUNOGENICITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN SECRETION; SITE DIRECTED MUTAGENESIS; VIRION; VIRUS REPLICATION; WESTERN BLOTTING; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL LINE; GENETICS; HEPATITIS B; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN TRANSPORT; VIROLOGY;

HEPATITIS B VIRUS; MUS;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; FEMALE; GLYCOSYLATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; VIRUS REPLICATION;

EID: 76249099842     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.012740-0     Document Type: Article

References (33)

1. Alexopoulou, A., Baltayiannis, G., Jammeh, S., Waters, J., Dourakis, S. P. & Karayiannis, P. (2004). Hepatitis B surface antigen variant with multiple mutations in the a determinant in an agammaglobulinemic patient. J Clin Microbiol 42, 2861-2865.
2. Carman, W. F. (1997). The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4 (Suppl. 1), 11-20.
3. Carman, W. F., Zanetti, A. R., Karayiannis, P., Waters, J., Manzillo, G., Tanzi, E., Zuckerman, A. J. & Thomas, H. C. (1990). Vaccine-induced escape mutant of hepatitis B virus. Lancet 336, 325-329.
4. Carman, W. F., Owsianka, A., Wallace, L. A., Dow, B. C. & Mutimer, D. J. (1999). Antigenic characterization of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hepatitis B immune globulin. J Hepatol 31, 195-201.
5. Chen, J., Fang, F., Li, X., Chang, H. & Chen, Z. (2005). Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Vaccine 23, 4322-4328.
6. Cooreman, M. P., Leroux-Roels, G. & Paulij, W. P. (2001). Vaccine-and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8, 237-247.
7. Gavel, Y. & von Heijne, G. (1990). Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng 3, 433-442.
8. Grethe, S., Monazahian, M., Böhme, I. & Thomssen, R. (1998). Characterization of unusual escape variants of hepatitis B virus isolated from hepatitis B surface antigen-negative subject. J Virol 72, 7692-7696.
9. Gunther, S., Fischer, L., Pult, I., Sterneck, M. & Will, H. (1999). Naturally occurring variants of hepatitis B virus. Adv Virus Res 52, 25-137.
10. Hou, J., Wang, Z., Cheng, J., Lin, Y., Lau, G. K., Sun, J., Zhou, F., Waters, J., Karayiannis, P. & Luo, K. (2001). Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34, 1027-1034.
11. Ireland, J. H., O'Donnell, B., Basuni, A. A., Kean, J. D., Wallace, L. A., Lau, G. K. K. & Carman, W. F. (2000). Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31, 1176-1182.
12. Kaplan, H. A., Welply, J. K. & Lennarz, W. J. (1987). Oligosaccharyl transferase: the central enzyme in the pathway of glycoprotein assembly. Biochim Biophys Acta 906, 161-173.
13. Karayiannis, P., Alexopoulou, A., Hadziyannis, S., Thursz, M., Watts, R., Seito, S. & Thomas, H. C. (1995). Fulminant hepatitis associated with hepatitis B virus e antigen-negative infection: importance of host factors. Hepatology 22, 1628-1634.
14. Kay, A. & Zoulim, F. (2007). Hepatitis B virus genetic variability and evolution. Virus Res 127, 164-176.
15. Lei, Y. C., Hao, Y. H., Zhang, Z. M., Tian, Y. J., Wang, B. J., Yang, Y., Zhao, X. P., Lu, M. J., Gong, F. L. & Yang, D. L. (2006). Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo. World J Gastroenterol 12, 4492-4497.
16. Lu, M. & Lorentz, T. (2003). De novo infection in a renal transplant recipient caused by novel mutants of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J Infect Dis 187, 1323-1326.
17. Marshall, R. D. (1974). The nature and metabolism of the carbohydrate-peptide linkages of glycoproteins. Biochem Soc Symp 40, 17-26.
18. Mellquist, J. L., Kasturi, L., Spitalnik, S. L. & Shakin-Eshleman, S. H. (1998). The amino acid following an asn-X-Ser /Thr sequon is an important determinant of N-linked core glycosylation efficiency. Biochemistry 37, 6833-6837.
19. Meng, Z., Xu, Y., Wu, J., Tian, Y., Kemper, T., Bleekmann, B., Roggendorf, M., Yang, D. & Lu, M. (2008). Inhibition of hepatitis B virus gene expression and replication by endoribonuclease-prepared siRNA. J Virol Methods 150, 27-33.
20. Okamoto, H.,Imai, M., Tsuda, F., Tanaka, T., Miyakawa, Y. & Mayumi, M. (1987). Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol 61, 3030-3034.
21. Parekh, S., Zoulim, F., Ahn, S. H., Tsai, A., Li, J., Kawai, S., Khan, N., Trepo, C., Wands, J. & Tong, S. (2003). Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants. J Virol 77, 6601-6612.
22. Peterson, D. L. (1981). Isolation and characterization of the major protein and glycoprotein of hepatitis B surface antigen. J Biol Chem 256, 6975-6983.
23. Schmitt, S., Glebe, D., Alving, K., Tolle, T. K., Linder, M., Geyer, H., Linder, D., Peter-Katalinic, J., Gerlich, W. H. & Geyer, R. (1999). Analysis of the pre-S2 N- and O-linked glycans of the M surface protein from human hepatitis B virus. J Biol Chem 274, 11945-11957.
24. Seddigh-Tonekaboni, S., Waters, J. A., Jeffers, S., Gehrke, R., Ofenloch, B., Horsch, A., Hess, G., Thomas, H. C. & Karayiannis, P. (2000). Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60, 113-121.
25. Shi, X. & Elliott, R. M. (2004). Analysis of N-linked glycosylation of hantaan virus glycoproteins and the role of oligosaccharide side chains in protein folding and intracellular trafficking. J Virol 78, 5414-5422.
26. Tai, P. C., Suk, F. M., Gerlich, W. H., Neurath, A. R. & Shih, C. (2002). Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants. Virology 292, 44-58.
27. Tian, Y., Xu, Y., Zhang, Z., Meng, Z., Qin, L., Lu, M. & Yang, D. (2007). The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45, 2971-2978.
28. Wang, Q., Wang, Y., Liang, C., Song, J. & Chen, X. (2008). Identification of a hydrophobic domain of HA2 essential to morphogenesis of Helicoverpa armigera nucleopolyhedrovirus. J Virol 82, 4072-4081.
29. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M. & other authors (2003). Antibody neutralization and escape by HIV-1. Nature 422, 307-312.
30. Weinberger, K. M., Bauer, T., Bohm, S. & Jilg, W. (2000). High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81, 1165-1174.
31. Widera, G., Austin, M., Rabussay, D., Goldbeck, C., Barnett, S. W., Chen, M., Leung, L., Otten, G. R., Thudium, K. & other authors (2000). Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164, 4635-4640.
32. Zhang, M., Gaschen, B., Blay, W., Foley, B., Haigwood, N., Kuiken, C. & Korber, B. (2004). Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. Glycobiology 14, 1229-1246.
33. Zheng, X., Weinberger, K. M., Gehrke, R., Isogawa, M., Hilken, G., Kemper, T., Xu, Y., Yang, D., Jilg, W. & other authors (2004). Mutant hepatitis B virus surface antigens (HBsAg) are immunogenic but may have a changed specificity. Virology 329, 454-464.